US FDA Struggling With Long-Term Follow-Up Requirements For Gene Therapies

 
• By Derrick Gingery
  
long-term
Many data collection hurdles could arise in the 15-year follow-up period for gene therapy patients. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Cell & Gene Therapies

More from Advanced Technologies